Xeris Pharmaceuticals | Kortsiktig Gjeld



Current Liabilities Endring Dato
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Celltrion KRW 3.03T 141.48B 2024-09
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 18.45M 2.74M 2024-12
Ecofibre AUD 20.78M 803K 2024-06
Eli Lilly USD 28.38B 3.7B 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pharma Mar EUR 82.69M 6.75M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Tilray USD 278.52M 15.02M 2024-11
Zz Pientze Pharmaceu 3.1B 569.38M 2024-09



Xeris Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.